Dr. Jeffrey M. Apple, M.D.
General Surgery (Surgery Physician)
- Medicare participating
At a glance
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 572
Licensed in Texas since 2000, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Surgery Physician primary
TX license K9991 (first issued 2000; active) -
Vascular Surgery Physician
OK license 44401
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St David's Medical Center Austin, TX
- North Austin Medical Center Austin, TX
- Round Rock Medical Center Round Rock, TX
Medical groups
- St Davids Heart and Vascular PLLC (203 clinicians)
- Cardiothoracic and Vascular Surgeons,pa (34 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 572
- Services billed
- 1,564
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 298 | 238 |
| New patient office or other outpatient visit, 45-59 minutes | 141 | 141 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 136 | 119 |
| New patient office or other outpatient visit, 30-44 minutes | 95 | 95 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 81 | 40 |
| Ultrasound of both sides of head and neck blood flow | 62 | 57 |
| Established patient office or other outpatient visit, 30-39 minutes | 55 | 53 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | 48 |
| Ultrasound study of arm and leg arteries | 53 | 40 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 34 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Austin, TX | 112 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Austin, TX | 69 |
| Lidocaine-Prilocaine (lidocaine/prilocaine) Other prescribers in Austin, TX | 69 |
| Xarelto (rivaroxaban) Other prescribers in Austin, TX | 54 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 47 payments worth $3,256 in total to this clinician.
| Medtronic, Inc. | $1,430 |
|---|---|
| Penumbra, Inc. | $591 |
| Cook Medical LLC | $217 |
| Atricure, Inc. | $207 |
| Inspiremd LTD | $186 |
| Stryker Corporation | $137 |
| Boston Scientific Corporation | $117 |
| Ethicon US, LLC | $102 |
| Food and Beverage | $1,881 |
|---|---|
| Consulting Fee | $1,375 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Dec 1, 2025 | Consulting Fee | $1,375 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $21,966 in research payments for these studies, mostly to the institutions running them.
- AGILITY BDPI-20-010
Bard Peripheral Vascular, Inc. - Roadster 3
Boston Scientific Corporation - A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of peripheral arterial disease: MIMICS-3D-USA
Veryan Medical Incorporated - Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease
Boston Scientific Corporation · Completed · NCT05365490
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.